Position in CELC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
-$264,348 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
10 quarters on record
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Derivatives in CELC
reported options exposure · as of Jun 30, 2026CallValue
$20,871,690
CallShares
199,500
PutValue
$19,888,262
PutShares
190,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,364,063,764 across 292 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in CELC
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,888,262 | 190,100 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $20,871,690 | 199,500 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $264,348 | 2,316 | Shares | Defined | 2026-05-12 | |
| 2026-03-31 | $2,876,328 | 25,200 | Put | Defined | 2026-05-12 | |
| 2026-03-31 | $30,007,406 | 262,900 | Call | Defined | 2026-05-12 | |
| 2025-12-31 | $20,556,414 | 206,100 | Call | Defined | 2026-02-12 | |
| 2025-12-31 | $508,674 | 5,100 | Put | Defined | 2026-02-12 | |
| 2025-09-30 | $12,088,870 | 244,714 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $207,480 | 4,200 | Put | Defined | 2025-11-14 | |
| 2024-09-30 | $209,932 | 14,080 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $393,135 | 24,001 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $669,296 | 30,986 | Shares | Defined | 2024-05-16 | |
| 2023-03-31 | $269,144 | 26,258 | Shares | Defined | 2023-05-16 | |
| 2021-09-30 | $194,328 | 10,796 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $207,096 | 8,629 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||